Fig. 1From: Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicityEffect of different Irinotecan concentrations on the growth kinetics of three selected E.coli isolates; (A) E. coli AF01, (B) E. coli AF02, and (C) E. coli AF03. * p < 0.05 ** p < 0.01Back to article page